| Sickle cell Trevor Thompson transition project (ST3P-UP) protocol for managing care transitions: Methods and rationale. | Osunkwo I, Lawrence R, Robinson M, Patterson C, Symanowski J, Minniti C, Bryant P, Williams J, Eckman J, Desai P | Contemp Clin Trials | 2023 |
| Understanding the Association between Red Blood Cell Transfusion Utilization and Humanistic and Economic Burden in Patients with β-Thalassemia from the Patients' Perspective. | Knoth RL, Gupta S, Perkowski K, Costantino H, Inyart B, Ashka L, Clapp K | J Clin Med | 2023 |
| Therapeutic adenine base editing of human hematopoietic stem cells. | Liao J, Chen S, Hsiao S, Jiang Y, Yang Y, Zhang Y, Wang X, Lai Y, Bauer DE, Wu Y | Nat Commun | 2023 |
| Classification of red cell dynamics with convolutional and recurrent neural networks: a sickle cell disease case study. | Darrin M, Samudre A, Sahun M, Atwell S, Badens C, Charrier A, Helfer E, Viallat A, Cohen-Addad V, Giffard-Roisin S | Sci Rep | 2023 |
| Optical coherence tomography angiography findings in transfusion-dependent beta-thalassemia patients with and without splenectomy. | Koctekin B, Karakus V, Dogan B, Erdem R, Dogan U, Buber H, Kurtoglu E | Photodiagnosis Photodyn Ther | 2023 |
| Electrophysiological properties and heart rate variability of patients with thalassemia major in Jakarta, Indonesia. | Sukardi R, Wahidiyat PA, Gultom PA, Ikhsan M, Yamin M, Salim S, Djer MM | PLoS One | 2023 |
| Left ventricular global function index is associated with myocardial iron overload and heart failure in thalassemia major patients. | Meloni A, Positano V, Pistoia L, Righi R, Missere M, Grassedonio E, Schicchi N, Vallone A, Gamberini MR, Cuccia L, Lisi R, Cecinati V, Spasiano A, Cademartiri F | Int J Cardiovasc Imaging | 2023 |
| Transfusion-transmitted babesiosis in a patient with sickle cell disease undergoing chronic red cell exchange. | Costa V, Mercure-Corriveau N, Gourneau J, Tobian AAR, Jones JM, Lauriello A, Lanzkron S, Crowe EP, Bloch EM | Transfusion | 2023 |
| Foetal haemoglobin inducers for reducing blood transfusion in non-transfusion-dependent beta-thalassaemias. | Foong WC, Loh CK, Ho JJ, Lau DS | Cochrane Database Syst Rev | 2023 |
| Impact of Hemin on Interleukin-21 Levels and Plasma Cells in Transfusion-Dependent Thalassemia with Positive and Negative Allo-Autoantibody. | Tambunan BA, Ugrasena IDG, Aryati A | Int J Gen Med | 2023 |
| Patient and Caregiver Perspectives on Care-Seeking During a Vaso-Occlusive Crisis in Sickle Cell Disease: Results from Qualitative Interviews in Canada. | Durgam N, Brion T, Lewis HB, Tinga B, Sanon W, Lundie M, Cadieux C | Patient Prefer Adherence | 2023 |
| Dual diagnosis of autosomal dominant polycystic kidney disease and sickle cell disease in a teenage male. | Stein Q, Herman K, Deyo J, McDonough C, Bloom MS, Mansuri A | Pediatr Nephrol | 2023 |
| Prevalence and Risk Factors for Pulmonary Embolism in Pediatric Sickle Cell Disease: A National Administrative Database Study. | Bala N, Stanek J, Rodriguez V, Villella A | Pediatr Hematol Oncol | 2023 |
| Labile plasma iron and echocardiographic parameters are associated to cardiac events in β-thalassemic patients. | Ferrara F, Coppi F, Riva R, Ventura P, Ricci A, Mattioli AV, Talarico M, Garuti C, Bevini M, Rochira V, Buzzetti E, Pietrangelo A, Corradini E | Eur J Clin Invest | 2023 |
| A reliable and high throughput HPLC-HRMS method for the rapid screening of β-thalassemia and hemoglobinopathy in dried blood spots. | Li Z, Chen D, Shu Y, Yang J, Zhang J, Ming Wang , Wan K, Zhou Y, He X, Zou L, Yu C | Clin Chem Lab Med | 2023 |
| Sleep disordered breathing and its relation to stroke and pulmonary hypertension in children with sickle cell disease: a single-center cross-sectional study. | Tantawy A, El-Sherif N, Makkeyah S, Eldeen NS, Farghal NBE, Soliman N, Ebeid FSE | Ann Hematol | 2023 |
| Oxidants and Antioxidants in the Redox Biochemistry of Human Red Blood Cells. | Möller MN, Orrico F, Villar SF, López AC, Silva N, Donzé M, Thomson L, Denicola A | ACS Omega | 2023 |
| Automated Good Manufacturing Practice-Compatible CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells for Clinical Treatment of β-Hemoglobinopathies. | Ureña-Bailén G, Block M, Grandi T, Aivazidou F, Quednau J, Krenz D, Daniel-Moreno A, Lamsfus-Calle A, Epting T, Handgretinger R, Wild S, Mezger M | CRISPR J | 2023 |
| Enuresis and overactive bladder in sickle cell patients: a narrative review of the literature. | Gaye O, Seck M, Thiam NM, Ndong A, Fall PA | World J Urol | 2023 |
| Factors Associated with Leg Ulcers in Adults with Sickle Cell Disease in Brazil. | Reis de Souza V, Kelly S, Cerdeira Sabino E, Mendes de Oliveira F, Silva T, Miranda Teixeira C, Máximo C, Loureiro P, Barbara de Freitas Carneiro-Proietti A, Gomes I, Custer B, de Almeida-Neto C | Adv Skin Wound Care | 2023 |
| Epidemiological Surveillance of SARSCov2 in β-Thalassemia Patients in the Last Two Years: Reinfection Rate, Insights and Future Challenges. | Torti L, Sorrentino F, Maffei L, De Fabritiis P, Abruzzese E | Mediterr J Hematol Infect Dis | 2023 |
| Glucose Homeostasis and Assessment of β-Cell Function by 3-hour Oral Glucose Tolerance (OGTT) in Patients with β-Thalassemia Major with Serum Ferritin below 1,000 ng/dL: Results from a Single ICET-A Centre. | de Sanctis V, Soliman AT, Daar S, Tzoulis P, Di Maio S, Kattamis C | Mediterr J Hematol Infect Dis | 2023 |
| Adverse Pregnancy Outcomes in Sickle Cell Trait: a Prospective Cohort Study Evaluating Clinical and Haematological Parameters in Postpartum Mothers and Newborns. | Ali EH, Alkindi S, Mohamed AO, Awadalla KE, Abdlgadir O, Adam G, Magdi M, Ibrahim AK, Ghebremeskel K | Mediterr J Hematol Infect Dis | 2023 |
| The Burden of Sickle Cell Disease in Saudi Arabia: A Single-Institution Large Retrospective Study. | Bin Zuair A, Aldossari S, Alhumaidi R, Alrabiah M, Alshabanat A | Int J Gen Med | 2023 |
| A specific G9a inhibitor unveils BGLT3 lncRNA as a universal mediator of chemically induced fetal globin gene expression. | Takase S, Hiroyama T, Shirai F, Maemoto Y, Nakata A, Arata M, Matsuoka S, Sonoda T, Niwa H, Sato S, Umehara T, Shirouzu M, Nishigaya Y, Sumiya T, Hashimoto N, Namie R, Usui M, Ohishi T, Ohba SI, Kawada M, Hayashi Y, Harada H, Yamaguchi T, Shinkai Y, Nakamura Y, Yoshida M, Ito A | Nat Commun | 2023 |
| CRISPR-Cas9 base editors and their current role in human therapeutics. | Lahr WS, Sipe CJ, Skeate JG, Webber BR, Moriarity BS | Cytotherapy | 2023 |
| Early recognition of pulmonary complications of sickle cell disease. | Almusally RM | Saudi Med J | 2023 |
| Physical, Mental, and Social Health of Adult Patients with Sickle Cell Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Mixed-Methods Study. | Dovern E, Nijland SJAM, van Muilekom MM, Suijk EMJ, Hoogendoorn GM, Mekelenkamp H, Biemond BJ, Haverman L, Nur E | Transplant Cell Ther | 2023 |
| Clinical Utility of Neutrophil to Lymphocyte Ratio in Sickle Cell Disease With Vaso-Occlusive Crisis. | Maharaj S, Chang S | Hematol Oncol Stem Cell Ther | 2023 |
| Use of Multiple Urinary Biomarkers for the Early Detection of Chronic Kidney Disease in Sickle Cell Anemia. | Castro Sesquen Y, Saraf SL, Gordeuk VR, Nekhai S, Jerebtsova M | Blood Adv | 2023 |
| Is CBD ready for prime time in sickle cell disease? | Curtis SA, Novelli EM | Blood | 2023 |
| Ups and downs in the treatment of sickle cell disease. | Brousse V | Blood | 2023 |
| (De)ironing out sickle cell disease. | Das NK, Shah YM | Blood | 2023 |
| Cognitive Function in Children With β-thalassemia Major. | Kurian AK, Sharma M, Varughese PV, Aggarwal N | Indian Pediatr | 2023 |
| Membrane bending and sphingomyelinase associated sulfatide dependent hypoxic adhesion of sickle mature erythrocytes. | Goreke U, Kucukal E, Wang F, An R, Arnold N, Quinn E, Yuan C, Bode A, Hill A, Man Y, Hambley BC, Schilz R, Ginwalla M, Little J, Gurkan UA | Blood Adv | 2023 |
| Sickle Cell Disease Gene Therapy Trial Paused. | Larkin HD | JAMA | 2023 |
| Associations of the serum albumin concentration and Sequential Organ Failure Assessment score at discharge with 1-year mortality in sepsis survivors: A retrospective cohort study. | Lee SM, Jo YH, Lee JH, Hwang JE, Park I, Baek S, Jeong H, Um YW, Kim HE | Shock | 2023 |
| Comment on: Impact of telehealth visits on hydroxyurea response in sickle cell anemia. | Cheema MRS | Pediatr Blood Cancer | 2023 |
| Social inequalities in the temporal trend of mortality from sickle cell disease in Brazil, 1996-2019. | Cordovil K, Tassinari W, Oliveira RVC, Hökerberg Y | Cad Saude Publica | 2023 |
| Identification of novel mutations in β-thalassemia patients in Maysan Governorate, Iraq. | Al-Hameedawi AKJ, Al-Shawi AAA | Mol Biol Rep | 2023 |
| TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis. | Ganz T, Nemeth E, Rivella S, Goldberg P, Dibble AR, McCaleb ML, Guo S, Monia BP, Barrett TD | Adv Ther | 2023 |
| Hematopoietic stem cell transplant start-up in Iraqi Kurdistan: results on thalassemia patients and analysis of the methodology. | Verna M, Canesi M, Conter V, Faulkner L, Rovelli AM, Silvestri D, Majolino I, Biondi A, Abdullah CN, Mohammed VF | Transplant Cell Ther | 2023 |
| The association between renal function decline and disease severity in sickle cell disease. | Gaartman AE, van Tuijn CFJ, Nur E, Vogt L, Biemond BJ | Am J Hematol | 2023 |
| "Double-hit" ineffective erythropoiesis -concurrent β-thalassemia with α-gene triplication and Myelodysplastic Syndrome with SF3B1 mutation | Chen PH, Gorshein E, Tormey C, Siddon AJ, Perincheri S | Am J Hematol | 2023 |
| Evaluating the Clinical Utility of a Long-Read Sequencing-Based Approach in Prenatal Diagnosis of Thalassemia. | Liang Q, He J, Li Q, Zhou Y, Liu Y, Li Y, Tang L, Huang S, Li R, Zeng F, Mao A, Liu Y, Liang D, Wu L | Clin Chem | 2023 |
| A Case of Misdiagnosis Caused by the Coinheritance of Hb G-Siriraj [β7(A4)Glu→Lys; : c.22G>A] and Hb H Disease. | Guan ZY, Zhong ZY, Xu ZB, Chen JH, Liu YH | Hemoglobin | 2023 |
| Use of Capillary Electrophoresis Migration Position for the Presumptive Identification of Hemoglobin Variants Prevalent in China. | Xu M, Li MY, Zeng Y, Xie W, Xu AP, Ji L | Hemoglobin | 2023 |
| Preschool Pain Management Program for Young Children with Sickle Cell Disease: A Pre-Post Feasibility Study. | Johnston JD, Schatz J, Bills SE, Frye BG, Carrara GC | J Pediatr Psychol | 2023 |
| Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease. | Sparkenbaugh EM, Henderson MW, Miller-Awe MD, Abrams C, Ilich A, Trebak F, Ramadas N, Vital SA, Bohinc D, Bane K, Chen C, Patel M, Wallisch M, Renné T, Gruber A, Cooley B, Gailani D, Kasztan M, Vercellotti GM, Belcher JD, Gavins FNE, Stavrou EX, Key NS, Pawlinski R | Blood | 2023 |
| Development of molecular diagnostic platform for α -thalassemia 44.6 kb (Chiang Rai, -- ) deletion in individuals with microcytic red blood cells across Thailand. | Khamphikham P, Hanmanoviriya O, Wongpalee SP, Munkongdee T, Paiboonsukwong K, Jopang Y, Wangchauy C, Sancharernsook C, Jinorose N, Pornprasert S | Ann Hum Genet | 2023 |
| [Splenic dysfunction in sickle cell disease: An update]. | Tennenbaum J, Volle G, Buffet P, Ranque B, Pouchot J, Arlet JB | Rev Med Interne | 2023 |
| Transplant for non-malignant disorders: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineering. | Klein OR, Bonfim C, Abraham A, Ruggeri A, Purtill D, Cohen S, Wynn R, Russell A, Sharma A, Ciccocioppo R, Prockop S, Boelens JJ, Bertaina A | Cytotherapy | 2023 |
| Design of an adaptive randomized clinical trial of intravenous citrulline for sickle cell pain crisis in the emergency department. | Majumdar S, McKinley KW, Chamberlain J, Thomas B, Margulies S, Nickel RS, Darbari DS, Campbell A, Berul C, Summar M, Kalsi G | Contemp Clin Trials Commun | 2023 |
| Safety and Efficacy of Thalidomide and Hydroxyurea Combination in Beta Thalassemia Patients. | Garg A, Patel K, Shah K, Trivedi D, Raj A, Yadav R, Shah S | Indian J Hematol Blood Transfus | 2023 |
| Pre-Transplant Immunosuppression for High Risk Thalassaemia: A Ray of Hope. | Bharadwaj R, Kumar G V, M D | Indian J Hematol Blood Transfus | 2023 |
| A First Clinical and Molecular Study of Rare IVS-II-806 (G > C) (HBB:c.316-45G > C) Variant in the β-globin Gene: A Possibly Benign Variant. | Zhuang J, Luo Q, Zeng S, Chen Y, Lin S, Wang Y, Jiang Y | Indian J Hematol Blood Transfus | 2023 |
| Association of Sickle Cell Disease With Severe Maternal Morbidity. | Ha TK, Boulet SL, Cotsonis G, Geary F, Jamieson DJ, Lindsay M | Obstet Gynecol | 2023 |
| Suboptimal dalbavancin dosages in an adult with sickle-cell disease and glomerular hyperfiltration. | Abdellaoui S, Gregoire M, Dubert M, Cheminet G, Arlet JB, Lafont E | J Antimicrob Chemother | 2023 |
| Iron chelation therapy. | Bruzzese A, Martino EA, Mendicino F, Lucia E, Olivito V, Bova C, Filippelli G, Capodanno I, Neri A, Morabito F, Gentile M, Vigna E | Eur J Haematol | 2023 |
| Expecting more: the case for incorporating fertility services into comprehensive sickle cell disease care. | Pecker LH, Oteng-Ntim E, Nero A, Lanzkron S, Christianson MS, Woolford T, Meacham LR, Mishkin AD | Lancet Haematol | 2023 |
| The Novel Role of the B-Cell Lymphoma/Leukemia 11A (BCL11A) Gene in β-Thalassaemia Treatment. | Hassan Mahmoud N, Lai MI | Cardiovasc Hematol Disord Drug Targets | 2023 |
| Zinc for infection prevention in children with sickle cell anemia: a randomized double-blind placebo-controlled trial. | Namazzi R, Opoka RO, Conroy AL, Datta D, Tagoola A, Bond C, Goings MJ, Ryu MS, Cusick SE, Krebs NF, Jang JH, Tu WF, Ware RE, John CC | Blood Adv | 2023 |
| Cerebral artery conditional blood velocity in sickle cell disease: a multicentre study and evidence for active treatment. | Modebe E, Nonyelu C, Duru A, Ezenwosu O, Chukwu B, Madu A, Ezekekwu C, Aneke J, Izuka M, Nri-Ezedi C, Nnachi O, Eze A, Ajuba I, Okwummuo E, Chilaka J, Onodugo C, Fidelis-Ewa U, Agwu O, Anigbogu I, Muoghalu E, Okoye H, Efobi C, Ejiofor O, Ugwu N, Maduka C, Iloanusi N, Ugwu A, Okocha C, Ulasi T, Okpala I | Arch Dis Child | 2023 |
| Luspatercept in combination with recombinant erythropoietin in patients with myelodysplastic syndrome with ring sideroblasts: Stimulating early and late-stage erythropoiesis. | Fattizzo B, Versino F, Bortolotti M, Rizzo L, Riva M, Barcellini W | Eur J Haematol | 2023 |
| A systematic review comparing allogeneic hematopoietic stem cell transplant to gene therapy in sickle cell disease. | Rotin LE, Viswabandya A, Kumar R, Patriquin CJ, Kuo KHM | Hematology | 2023 |
| Severe Maternal Morbidity and Mortality in Sickle Cell Disease in the National Inpatient Sample, 2012-2018. | Early ML, Eke AC, Gemmill A, Lanzkron S, Pecker LH | JAMA Netw Open | 2023 |
| Comparisons of Severe Maternal Morbidity and Other Adverse Pregnancy Outcomes in Pregnant People With Sickle Cell Disease vs Anemia. | Early ML, Eke AC, Gemmill A, Lanzkron S, Pecker LH | JAMA Netw Open | 2023 |
| Microfluidic study of retention and elimination of abnormal red blood cells by human spleen with implications for sickle cell disease. | Qiang Y, Sissoko A, Liu ZL, Dong T, Zheng F, Kong F, Higgins JM, Karniadakis GE, Buffet PA, Suresh S, Dao M | Proc Natl Acad Sci U S A | 2023 |
| Treatment of dental and orthodontic complications in thalassaemia. | Mulimani P, Abas AB, Karanth L, Colombatti R, Kulkarni P | Cochrane Database Syst Rev | 2023 |
| "Long-term efficacy and safety of L-glutamine in preventing sickle cell disease-related acute complications and haemolysis in paediatric and adult patients - real-world, observational study" | Elenga N, Loko G, Etienne-Julan M, Al-Okka R, Adel AM, Yassin MA | Eur J Haematol | 2023 |
| Comparing the effects of self- care education by lecture and smartphone application on self-efficacy of patients with thalassemia. | Kharaman-Nia F, Rezaei H, Roustaei N, Etemadfar P, Hosseini N | BMC Med Inform Decis Mak | 2023 |
| The management of chronic pain in sickle cell disease: an interview with Nadine Matthie. | Matthie NS | Pain Manag | 2023 |
| Transamniotic Fetal Administration of Genetically Modified Hematopoietic Stem Cells Carrying a Human Transgene in a Syngeneic Rat Model. | Labuz D, Whitlock A, Kycia I, Zurakowski D, Fauza DO | Stem Cells Dev | 2023 |
| Patients with sickle cell disease are let down by lack of coordinated NHS care, report finds. | Kmietowicz Z | BMJ | 2023 |
| Refractory Pneumonia in a 12-year-old Girl with Hemoglobin SS Disease. | Tregoning VG, Parran K, Watson AS, Mitchell ML | Pediatr Rev | 2023 |
| Polymorphisms and gene expression of metalloproteinases and their inhibitors associated with cerebral ischemic stroke in young patients with sickle cell anemia. | do Kleyton Palmeira Ó, da Silva Freire AK, de Nóbrega DN, Dos Santos Souza R, Farias ICC, de Mendonça Belmont TF, da Silva AS, da Silva Arcanjo G, da Silva Araujo A, Dos Anjos ACM, de Araujo ARL, Bezerra MAC, de Moura PMMF, do Socorro Mendonça Cavalcanti M, Vasconcelos LRS | Mol Biol Rep | 2023 |
| Analytical and Clinical Significance of Rare Hemoglobin Variants during HbA1c Monitoring in Patients with Diabetes Mellitus: Two Cases of Hemoglobin G-Ferrara and Hemoglobin G-Copenhagen in Diabetic Patients with Sickle Cell Trait. | Karimi SS, Jin M, Murga-Zamalloa C | J Appl Lab Med | 2023 |
| Lessons identified from initiating a thalassaemia programme in a conflict setting: a case study from northeast Syria. | MacVinish S, van Leeuwen C, Hoetjes M, Aoki Y, Foley D, Roggeveen H | Confl Health | 2023 |
| Kidney Transplantation in a Patient Affected by Sickle Cell Trait: A Case Report and State-of-the-Art Review. | Picciotto D, Bussalino E, Viazzi F, Paoletti E, Esposito P | Cureus | 2023 |
| analysis of substitution mutations in the β-globin gene in Turkish population of β-thalassemia. | Alkilani S, Sevimoglu T | J Biomol Struct Dyn | 2023 |
| An outpatient pain plan and ED pain pathway for adults with sickle cell disease. | Mercado SH | JAAPA | 2023 |
| New logarithm-based discrimination formula for differentiating thalassemia trait from iron deficiency anemia in pregnancy. | Shuang X, Zhenming W, Zhu M, Si S, Zuo L | BMC Pregnancy Childbirth | 2023 |
| An evaluation of deferiprone as twice-a-day tablets or in combination therapy for the treatment of transfusional iron overload in thalassemia syndromes. | Shah R, Shah A, Badawy SM | Expert Rev Hematol | 2023 |
| Improving the Emergency Department Management of Sickle Cell Vaso-Occlusive Pain Crisis: The Role and Options of Sublingual and Intranasally Administered Analgesia. | Ojo AS, Odipe OG, Owoseni O | J Clin Med Res | 2023 |
| Thalassaemia-A global view. | Hokland P, Daar S, Khair W, Sheth S, Taher AT, Torti L, Hantaweepant C, Rund D | Br J Haematol | 2023 |
| Alpha-Thalassemia in Southern Italy: Characterization of Five New Deletions Removing the Alpha-Globin Gene Cluster. | Cardiero G, Musollino G, Prezioso R, Nigro V, Lacerra G | Int J Mol Sci | 2023 |
| Pediatric Sickle Cell Disease and Stroke: A Literature Review. | Parikh T, Goti A, Yashi K, Gopalakrishnan Ravikumar NP, Parmar N, Dankhara N, Satodiya V | Cureus | 2023 |
| Combatting thalassemia in the United Arab Emirates. | Al-Oraimi SZ, Davey G | Int Health | 2023 |
| Leg Ulcers in Sickle Cell Disease: A Multifactorial Analysis Highlights the Hemolytic Profile. | Santos EDC, Santana PVB, Jesus LLS, Melo GIV, Yahouédéhou SCMA, Guarda CCD, Santiago RP, Fiuza LM, Carvalho SP, Santos LOD, Adorno EV, Aleluia ACM, Luiz LCGC, Fonseca TCC, Gonçalves MS, Aleluia MM | Hematol Rep | 2023 |
| Embryo Cryopreservation in a Patient with Sickle Cell Disease Utilizing Letrozole and Enoxaparin: A Case Report. | Gunderson SJ, Snowden N, Field JJ | Hematol Rep | 2023 |
| Association of GDF15 levels with body mass index and endocrine status in β-thalassaemia. | Karusheva Y, Petry CJ, Yasara N, Kottahachchi D, Premawardhena A, Barker P, Burling K, Sattar N, Welsh P, Mettananda S, O'Rahilly S | Clin Endocrinol (Oxf) | 2023 |
| Emerging drug targets for sickle cell disease: shedding light on new knowledge and advances at the molecular level. | Gibson JS, Rees DC | Expert Opin Ther Targets | 2023 |
| Vitamin D levels and left ventricular function in beta-thalassemia major with iron overload. | Pala M, Bhat KG, Manya S, Joseph N, Harish S | Eur J Pediatr | 2023 |
| Spontaneous extradural hematoma in a Sickle cell Beta Thalassemia patient-A rare complication. | Ghimire P, Ghimire PG | Clin Case Rep | 2023 |
| Non-invasive fetal genotyping for maternal alleles with droplet digital PCR: A comparative study of analytical approaches. | Shaw J, Scotchman E, Paternoster B, Ramos M, Nesbitt S, Sheppard S, Snowsill T, Chitty LS, Chandler N | Prenat Diagn | 2023 |
| Brain-derived neurotrophic factor and neuroimaging in pediatric patients with sickle cell disease. | Mahmoud AA, Abd El Naby SA, Abdelgawad AS, Rizq MS, Abd El Hady NMS | Pediatr Res | 2023 |
| A Framework for a Health Economic Evaluation Model for Patients with Sickle Cell Disease to Estimate the Value of New Treatments in the United States of America. | Winn A, Basu A, Ramsey SD | Pharmacoecon Open | 2023 |
| Mitochondria: Emerging Consequential in Sickle Cell Disease. | Akhter MS, Hamali HA, Rashid H, Dobie G, Madkhali AM, Mobarki AA, Oldenburg J, Biswas A | J Clin Med | 2023 |
| Comparison between Sickle Cell Disease Patients and Healthy Donors: Untargeted Lipidomic Study of Erythrocytes. | Alabed HBR, Gorello P, Pellegrino RM, Lancioni H, La Starza R, Taddei AA, Urbanelli L, Buratta S, Fernandez AGL, Matteucci C, Caniglia M, Arcioni F, Mecucci C, Emiliani C | Int J Mol Sci | 2023 |
| Next-Generation Sequencing (NGS) and Third-Generation Sequencing (TGS) for the Diagnosis of Thalassemia. | Hassan S, Bahar R, Johan MF, Mohamed Hashim EK, Abdullah WZ, Esa E, Abdul Hamid FS, Zulkafli Z | Diagnostics (Basel) | 2023 |
| [Effect of Recombinant Human Thrombopoietin (rhTPO) on Hematopoietic Reconstitution in Allogeneic Hematopoietic Stem Cell Transplantation Model]. | Qiu J, Han LY, Xing HY, Gao KL, Bian TR | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2023 |
| [Genotype and Phenotype of α-Thalassemia Fusion Gene in Huadu District of Guangzhou, Guangdong Province of China]. | Ju AP, Li YQ, Lin K, Liu SX, Qin YL, Yuan SX, Liang L | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2023 |
| Complementary and alternative medicine for children with sickle cell disease: A systematic review. | Alsabri M, Carfagnini C, Amin M, Castilo F, Lewis J, Ashkar M, Hamzah M, Mohamed N, Saker M, Mahgerefteh J, St Victor R, Peichev M, Kupferman F, Viswanathan K | Blood Rev | 2023 |
| Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials. | Lin C, Schwarzbach A, Sanz J, Montesinos P, Stiff P, Parikh S, Brunstein C, Cutler C, Lindemans CA, Hanna R, Koh LP, Jagasia MH, Valcarcel D, Maziarz RT, Keating AK, Hwang WYK, Rezvani AR, Karras NA, Fernandes JF, Rocha V, Badell I, Ram R, Schiller GJ, Volodin L, Walters MC, Hamerschlak N, Cilloni D, Frankfurt O, McGuirk JP, Kurtzberg J, Sanz G, Simantov R, Horwitz ME | Transplant Cell Ther | 2023 |
| Rapid MRI Assessment of Long-Axis Strain to Indicate Systolic Dysfunction in Patients With Sickle Cell Disease. | Grützediek K, Fischer R, Kurio G, Böckelmann L, Bleeke M, Hagar RW, Tahir E, Grosse R, Weyhmiller M, Adam G, Bannas P, Schoennagel BP | J Magn Reson Imaging | 2023 |
| [Molecular genetic characteristics of a family which coinheritance of rare-88 C>G () β-thalassemia mutation with α-thalassemia and review of the literature]. | Li W, Chen LT, Yu Y, Wang J, Li CY, Cai TE, Lu CJ, Li DX, Tian XJ | Zhonghua Yu Fang Yi Xue Za Zhi | 2023 |
| Risk of gout attack not increased in patients with thalassemia: a population-based cohort study. | Chen JW, Xu Q, Yang PD, Huang JY, Wei JC | Sci Rep | 2023 |
| Graphite Bio Pauses Lead Gene Editing Program in Sickle Cell Disease. | Philippidis A | Hum Gene Ther | 2023 |
| Using the consolidated framework for implementation research to identify recruitment barriers and targeted strategies for a shared decision-making randomized clinical trial in pediatric sickle cell disease. | Strong H, Hood AM, Johnson Y, Hackworth R, Reed-Shackelford M, Ramaswamy R, Varughese T, Quinn CT, Crosby LE | Clin Trials | 2023 |
| Relevance of Howell-Jolly body counts for measuring spleen function in sickle cell disease. | Pourdieu C, El Hoss S, Le Roux E, Pages J, Koehl B, Missud F, Holvoet L, Ithier G, Benkerrou M, Haouari Z, Da Costa L, El Nemer W, Laurance S, Aronovicz YC, Le Van Kim C, Fenneteau O, Lainey E, Brousse V | Am J Hematol | 2023 |
| In vivo HSC prime editing rescues Sickle Cell Disease in a mouse model. | Li C, Georgakopoulou A, Newby GA, Chen PJ, Everette KA, Paschoudi K, Vlachaki E, Gil S, Anderson AK, Koob T, Huang L, Wang H, Kiem HP, Liu DR, Yannaki E, Lieber A | Blood | 2023 |
| Most Adults with Severe HbSC Disease are not Treated with Hydroxyurea. | Ghunney WK, Asare EV, Ayete-Nyampong JB, Oppong SA, Rodeghier M, DeBaun MR, Olayemi E | Blood Adv | 2023 |
| Lack of hydroxyurea-associated mutagenesis in pediatric sickle cell disease patients. | Torous DK, Avlasevich S, Bemis JC, Howard T, Ware RE, Fung C, Chen Y, Sahsrabudhe D, MacGregor JT, Dertinger SD | Environ Mol Mutagen | 2023 |
| T helper 17 and regulatory T-cell profile and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in pediatric patients with beta-thalassemia. | Bayegi SN, Hamidieh AA, Behfar M, Saghazadeh A, Bozorgmehr M, Karamlou Y, Shekarabi M, Tajik N, Delbandi AA, Zavareh FT, Delavari S, Rezaei N | Transpl Immunol | 2023 |
| Discovery of a biomarker for β-Thalassemia by HPLC-MS and improvement from Proton Transfer Reaction - Parallel Ion Parking. | Lin Y, Agarwal AM, Anderson LC, Marshall AG | J Mass Spectrom Adv Clin Lab | 2023 |
| The future of sickle cell disease therapeutics rests in genomics. | Wonkam A | Dis Model Mech | 2023 |
| Social determinants of neurocognitive and academic performance in sickle cell disease. | Heitzer AM, Okhomina VI, Trpchevska A, MacArthur E, Longoria J, Potter B, Raches D, Johnson A, Porter JS, Kang G, Hankins JS | Pediatr Blood Cancer | 2023 |
| 'Only parents can understand the problems and needs of children with thalassaemia': parental activism for thalassaemia care in Northern India. | Unnithan M, Pachauli C, Chattoo S, Atkin K | Anthropol Med | 2023 |
| Strategies to improve healthcare services for patients with sickle cell disease in Nigeria: The perspectives of stakeholders. | Isa H, Okocha E, Adegoke SA, Nnebe-Agumadu U, Kuliya-Gwarzo A, Sopekan A, Ofakunrin AO, Ugwu N, Hassan AA, Ohiaeri C, Madu A, Diaku-Akinwumi I, Ekwem L, Dogara LG, Okoh D, Jasini J, Girei A, Ekwere T, Okolo A, Kangiwa U, Lawson J, Chianumba R, Brown B, Akinola N, Nwegbu M, Nnodu O | Front Genet | 2023 |
| UK media reporting of NICE recommendation of crizanlizumab for patients with sickle cell disease. | Buka RJ, Roy N, Nicolson PL | EJHaem | 2023 |
| Predictors and clinical complications associated with antiphospholipid antibodies in sickle cell disease. | Rivera CR, Srisuwananukorn A, Bajwa RJ, Gordeuk VR, Rauch J, Levine JS, Saraf SL | EJHaem | 2023 |
| Acute kidney injury in Jamaicans with sickle cell disease hospitalized with COVID-19 infection. | Fisher LA, Asnani M | EJHaem | 2023 |
| Impact of age-dependent red blood cell parameters on α-globin gene genotyping in children. | Nissen PH, Narvestad-Bøttger H, Kristensen HP, Winther-Larsen A | EJHaem | 2023 |
| Infrastructure for bioinformatics applications in Tanzania: Lessons from the Sickle Cell Programme. | Mwita LA, Mawalla WF, Mtiiye FR, Kandonga D, Kent J, Makani J, Sangeda RZ | PLoS Comput Biol | 2023 |
| Bosentan Attenuates Sickle Cell Disease Erythrocyte HbS Polymerization and Impaired Deformability Induced by Endothelin-1. | Alves LRT, Nobre CCG, Reis EM, Miranda-Alves L, Berto Junior C | Can J Physiol Pharmacol | 2023 |
| evaluation of the effect of sickle cell hemoglobin S, C and therapeutic transfusion on erythrocyte metabolism and cardiorenal dysfunction. | D'Alessandro A, Nouraie SM, Zhang Y, Cendali F, Gamboni F, Reisz JA, Zhang X, Bartsch KW, Galbraith MD, Gordeuk VR, Gladwin MT | bioRxiv | 2023 |
| Differential proteomic patterns of plasma extracellular vesicles show potential to discriminate β-thalassemia subtypes. | Li N, Wu B, Wang J, Yan Y, An P, Li Y, Liu Y, Hou Y, Qing X, Niu L, Ding X, Xie Z, Zhang M, Guo X, Chen X, Cai T, Luo J, Wang F, Yang F | iScience | 2023 |
| Hemoglobin-Based Oxygen Carriers: Where Are We Now in 2023? | Chen L, Yang Z, Liu H | Medicina (Kaunas) | 2023 |
| Early Strokes Are Associated with More Global Cognitive Deficits in Adults with Sickle Cell Disease. | Couette M, Forté S, Oudin Doglioni D, Mekontso-Dessap A, Calvet D, Kuo KHM, Bartolucci P | J Clin Med | 2023 |
| Near-Infrared Spectroscopy Demonstrates the Benefit of Erythracytapheresis in Sickle Cell Disease Adult Patients with Cerebral Vasculopathy. | Martino S, Turki RC, Zouiti F, Fort R, Pakdaman S, Forté S, Menouche D, Calvet D, Rupp T, Pirenne F, Bartolucci P | J Clin Med | 2023 |
| Sublingual Microcirculation Specificity of Sickle Cell Patients: Morphology of the Microvascular Bed, Blood Rheology, and Local Hemodynamics. | Sant S, Gouraud E, Boisson C, Nader E, Goparaju M, Cannas G, Gauthier A, Joly P, Renoux C, Merazga S, Hautier C, Connes P, Fenech M | Int J Mol Sci | 2023 |
| Routine Ophthalmological Examination Rates in Adults with Sickle Cell Disease Are Low and Must Be Improved. | Zulueta P, Minniti CP, Rai A, Toribio TJ, Moon JY, Mian UK | Int J Environ Res Public Health | 2023 |
| Caregivers' Perspective on the Psychological Burden of Living with Children Affected by Sickle Cell Disease in Kinshasa, the Democratic Republic of Congo. | Lelo PVM, Kitetele FN, Akele CE, Sam DL, Boivin MJ, Kashala-Abotnes E | Children (Basel) | 2023 |
| Prime Editing for Human Gene Therapy: Where Are We Now? | Godbout K, Tremblay JP | Cells | 2023 |
| Thrombo-Inflammation in COVID-19 and Sickle Cell Disease: Two Faces of the Same Coin. | Chiang KC, Gupta A, Sundd P, Krishnamurti L | Biomedicines | 2023 |
| The Role of Inflammation in The Cellular and Molecular Mechanisms of Cardiopulmonary Complications of Sickle Cell Disease. | Gbotosho OT, Gollamudi J, Hyacinth HI | Biomolecules | 2023 |
| [Carrier screening and prenatal diagnosis for thalassemia-associated mutations in Jiaxing area of Zhejiang]. | Jiang H, Zhou C, Yang L, Li S, Liu X | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2023 |
| [Genetic analysis of a child with Hemoglobin Santa Ana]. | Liu J, Yu J | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2023 |
| Management of Older Adults with Sickle Cell Disease: Considerations for Current and Emerging Therapies. | Oyedeji CI, Hodulik KL, Telen MJ, Strouse JJ | Drugs Aging | 2023 |
| Genotypic and Phenotypic Composition of Sickle Cell Disease in the Arab Population - A Systematic Review. | Ata F, Rahhal A, Malkawi L, Iqbal P, Khamees I, Alhiyari M, Yousaf Z, Qasim H, Alshurafa A, Sardar S, Javed S, Fernyhough L, Yassin M | Pharmgenomics Pers Med | 2023 |
| Gene therapy approaches for sickle cell anemia. | Ulas T, Dal MS | Transfus Apher Sci | 2023 |
| The effect of intermittent fasting on the clinical and hematological parameters of patients with sickle cell disease: A preliminary study. | Ahmed K, Abdu Y, Khasawneh S, Shukri A, Adam E, Mustafa S, Affas M, Mohamed Ibrahim MI, Al Zayed A, Yassin MA | Front Med (Lausanne) | 2023 |
| Prevalence Rate of Thalassemia Carriers among Individuals with Microcytosis or Hypochromia in Portugal. | Santos D, Barreto M, Kislaya I, Mendonça J, P Machado M, Lopes P, Matias Dias C, Faustino P | Acta Med Port | 2023 |
| Palatability and Acceptability of Flaxseed-Supplemented Foods in Children with Sickle Cell Disease. | Dike CR, Lebensburger J, Mitchell C, Darnell B, Morrow CD, Demark-Wahnefried W | Nutrients | 2023 |
| Natural history and rate of progression of retinopathy in adult sickle cell disease patients: an 11-year follow-up study. | Brandsen RP, Diederen RM, Bakhlakh S, Nur E, Schlingemann RO, Biemond BJ | Blood Adv | 2023 |
| A Rare Report of the Coexistence of Sickle Cell Disease, Neurofibromatosis Type 1, and Intracranial Hypertension in a Pediatric Patient. | Patel A, Winter T, Jain A | J Pediatr Hematol Oncol | 2023 |
| A high-throughput newborn screening approach for SCID, SMA, and SCD combining multiplex qPCR and tandem mass spectrometry. | Tesorero R, Janda J, Hörster F, Feyh P, Mütze U, Hauke J, Schwarz K, Kunz JB, Hoffmann GF, Okun JG | PLoS One | 2023 |
| Description of a Colocated Comprehensive Care Model for People With Sickle Cell and Comorbid Pulmonary Disease. | Pugh C, Zeno RN, Stanek J, Gillespie M, Kopp BT, Creary SE | J Pediatr Hematol Oncol | 2023 |
| Peripheral transient receptor potential vanilloid type 4 hypersensitivity contributes to chronic sickle cell disease pain. | Ehlers VL, Sadler KE, Stucky CL | Pain | 2023 |
| Echocardiographic Left Ventricular Hypertrophy and Geometric Patterns in Patients with Sickle Cell Anaemia. | Abba AM, Ladu AI, Bukar AA, Sulaiman MM, Abjah UM, Talle MA | West Afr J Med | 2023 |
| The Association Between Caregiver Coping and Youth Clinic Attendance and Health-Related Quality of Life in Pediatric Sickle Cell Disease. | Koskela-Staples NC, Evans C, Turner EM, Black LV, Fedele DA | J Pediatr Hematol Oncol | 2023 |
| Urinary Biomarkers for the Assessment of Acute Kidney Injury of Pediatric Sickle Cell Anemia Patients Admitted for Severe Vaso-occlusive Crises. | Farris N, Benoit SW, McNinch NL, Bodas P | J Pediatr Hematol Oncol | 2023 |
| Deferiprone and Iron-Maltol: Forty Years since Their Discovery and Insights into Their Drug Design, Development, Clinical Use and Future Prospects. | Kontoghiorghes GJ | Int J Mol Sci | 2023 |
| Pulmonary function in patients with transfusion-dependent thalassemia and its associations with iron overload. | Chan KC, Au CT, Leung AWK, Li AM, Li CK, Wong MMT, Li CST, Cheung HL, Fan P, Ling SC, Li RCH, Ha SY | Sci Rep | 2023 |
| Multi-Parametric Cardiac Magnetic Resonance for Prediction of Heart Failure Death in Thalassemia Major. | Meloni A, Pistoia L, Gamberini MR, Cuccia L, Lisi R, Cecinati V, Ricchi P, Gerardi C, Restaino G, Righi R, Positano V, Cademartiri F | Diagnostics (Basel) | 2023 |
| Hydroxyurea and stroke prevention in sickle cell anaemia: the challenge of application in sub-Saharan Africa. | Diop S, de Montalembert M | Lancet Haematol | 2023 |
| Gene Mutation Spectrum among Alpha-Thalassaemia Patients in Northeast Peninsular Malaysia. | Vijian D, Wan Ab Rahman WS, Ponnuraj KT, Zulkafli Z, Bahar R, Yasin N, Hassan S, Esa E | Diagnostics (Basel) | 2023 |
| α- and β-Genotyping of Thalassemia Patients Based on a Multimodal Liver MRI Radiomics Model: A Preliminary Study in Two Centers. | Xu F, Feng Q, Yi J, Tang C, Lin H, Liang B, Luo C, Guan K, Li T, Peng P | Diagnostics (Basel) | 2023 |
| A Particular Focus on the Prevalence of - and -Thalassemia in Western Sicilian Population from Trapani Province in the COVID-19 Era. | Daidone R, Carollo A, Perricone MP, Messina R, Balistreri CR | Int J Mol Sci | 2023 |
| Discovery-Based Proteomics Identify Skeletal Muscle Mitochondrial Alterations as an Early Metabolic Defect in a Mouse Model of β-Thalassemia. | Reboucas P, Fillebeen C, Botta A, Cleverdon R, Steele AP, Richard V, Zahedi RP, Borchers CH, Burelle Y, Hawke TJ, Pantopoulos K, Sweeney G | Int J Mol Sci | 2023 |
| Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial. | Ambrose EE, Latham TS, Songoro P, Charles M, Lane AC, Stuber SE, Makubi AN, Ware RE, Smart LR | Lancet Haematol | 2023 |
| Patient and Family Opioid Decision-Making for Pain Management in Sickle Cell Disease: A Qualitative Study. | Phillips S, Schlenz AM, D'Alton S, Johnson M, Kanter J | J Pain | 2023 |
| Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease. | Harris EM, Vilk E, Donado C, Williams A, Heeney MM, Solodiuk J, Greco C, Archer NM | Pediatr Blood Cancer | 2023 |
| Scoping Review of Predisposing Factors Associated with Sensorineural Hearing Loss in Sickle Cell Disease. | Ibekwe T, Nnodu O, Nnebe-Agumadu U, Dagwa I, Dahilo E, Ibekwe P, Rogers C, Ramma L | West Afr J Med | 2023 |
| Health literacy correlates with abbreviated full-scale IQ in adolescent and young adults with sickle cell disease. | Bhatt N, Calhoun C, Longoria J, Nwosu C, Howell KE, Varughese T, Kang G, Jacola LM, Hankins JS, King A | Pediatr Blood Cancer | 2023 |
| Epidemiological Survey of Hemoglobinopathies Based on Next-Generation Sequencing Platform in Hunan Province, China. | Xi H, Liu Q, Xie DH, Zhou X, Tang WL, Tang G, Zeng CY, Wang Q, Nie XH, Peng JP, Gao XY, Wu HL, Zhang HQ, Qiu L, Feng ZH, Wang SY, Zhou SX, He J, Zhou SH, Zhou FQ, Zheng JQ, Wang SY, Chen SP, Zheng ZF, Ma XY, Fang JQ, Liang CB, Wang H | Biomed Environ Sci | 2023 |
| The gene spectrum of thalassemia in Yangjiang of western Guangdong Province. | Liang HF, Liang WM, Xie WG, Lin F, Liu LL, Li LJ, Ge YY, Lu M, Liao YW, Zeng GK, Yao JX, Situ JW, Yang LY | Front Genet | 2023 |
| Effects of regional brain volumes on cognition in sickle cell anemia: A developmental perspective. | Hamdule S, Kölbel M, Stotesbury H, Murdoch R, Clayden JD, Sahota S, Hood AM, Clark CA, Kirkham FJ | Front Neurol | 2023 |
| Moyamoya Syndrome (MMS) in a Patient With Sickle Cell Disease (SCD) and Protein S Deficiency. | Saxena P, Alkaissi H, Chauhan R, Muthu J | Cureus | 2023 |
| Attitudes toward COVID-19 vaccine among pediatric patients with sickle cell disease and their caregivers. | Persaud Y, Mandrell BN, Sharma A, Carroll Y, Irvine M, Olufadi Y, Kang G, Hijano DR, Rai P, Hankins JS, Johnson LM | Pediatr Blood Cancer | 2023 |
| Cerebral fat embolism syndrome in a patient with homozygous sickle cell disease in the setting of multisystem inflammatory syndrome in children. | Sepulveda K, Issa T, Dubrocq G | Proc (Bayl Univ Med Cent) | 2023 |
| In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell-Related Injury. | Federti E, Matte A, Recchiuti A, Garello F, Ghigo A, El Nemer W, Terreno E, Amoresano A, Mattoscio D, Turrini F, Lebouef C, Janin A, Pantaleo A, Russo R, Marin M, Iatcencko I, Riccardi V, Siciliano A, Iolascon A, Brugnara C, De Franceschi L | Hemasphere | 2023 |
| Severe proliferative retinopathy in a patient with sickle cell trait. | Caranfa JT, Witkin AJ | Am J Ophthalmol Case Rep | 2023 |
| Clinical outcomes of children and adolescents with sickle cell disease and COVID-19 infection: A year in review at a metropolitan tertiary pediatric hospital. | Martin OY, Darbari DS, Margulies S, Nickel RS, Leonard A, Speller-Brown B, Martin B, Barber JR, Webb J, Majumdar S, Sharron MP, Campbell AD | Front Med (Lausanne) | 2023 |
| Single-cell profiling of ineffective erythropoiesis in a mouse model of β-thalassaemia intermedia. | Peng Y, Liang L, Zhang H, Liu H, Zhang G, Sun S, Guo X, Wang Y, Hu B, Liu R, Li Y, Nie L, Zhang J, Ye M, Ginzburg YZ, Lin Z, Yin B, Chen H, Liu J | Br J Haematol | 2023 |
| Inflammatory and senescence-associated mediators affect the persistence of humoral response to COVID-19 mRNA vaccination in transfusion-dependent beta-thalassemic patients. | Bordoni V, Casale M, Pinto VM, Carsetti R, Gianesin B, Gamberini MR, Mazdai L, Barella S, Denotti AR, Colavita F, Perrotta S, Maggio A, Pitrolo L, Quintino S, Caminati M, Mazzi F, Ceolan J, De Franceschi L, Forni GL, Locatelli F, Agrati C | Am J Hematol | 2023 |
| Screening for asthma in preschool children with sickle cell disease. | Chan KH, Stark JM, Mosquera RA, Brown DL, Menon N, Nguyen TT, Yadav A | J Asthma | 2023 |
| Hb Q-Thailand heterozygosity unlinked with the (-α/) α-thalassemia deletion allele identified by long-read SMRT sequencing: hematological and molecular analyses. | Qin D, Wang J, Yao C, Bao X, Liang J, Du L | Hematology | 2023 |
| Hb Santa Juana ( 108(G10) Asn > Ser): a low oxygen affinity hemoglobin variant in a family of Bosnian background. | Wildenberg NP, Rossi C, Kulozik AE, Kunz JB | Hematology | 2023 |
| Novel Promoter Mutation (:C.-139_-138del) Associated with β-Thalassemia Trait Detected by Next-Generation Sequencing in Southern China. | Pan L, Tian P, Chen S, Zhang R | Hemoglobin | 2023 |
| Case report: Successful treatment with plasma exchange in life-threatening hyperhemolytic syndrome unrelated to sickle cell disease. | Shaulov A, Rund D, Filon D, Nachmias B, Khalili A, Manny N, Zelig O | Transfusion | 2023 |
| The role of nurses to control beta thalassemia disease in Indonesia: A perspective. | Setiawan H, Firmansyah A, Richard SD | J Taibah Univ Med Sci | 2023 |
| The Effect of Sickle Cell Hemoglobinopathy on Pregnancy, Labor, Puerperium, and Fetal Outcome: A Retrospective Cohort Study From a Single Centre. | Rajauria S, Atreja CB, Mujalda A, Mujalda J, Yadav S, Kundal RK | Cureus | 2023 |
| Knowledge and nutrition-related practices among caregivers of adolescents with sickle cell disease in the Greater Accra region of Ghana. | Ohemeng A, Nartey EB, Quaidoo E, Ansong RS, Asiedu MS | BMC Public Health | 2023 |
| The diagnosis and molecular analysis of a novel 27.2 kb deletion causing α-thalassemia. | Wang G, Zou S, Li J, Wang X, Wu H, Tao Z, Zhang Q, Xu X, Zhou Y | Clin Biochem | 2023 |
| Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia. | Geneen LJ, Dorée C, Estcourt LJ | Cochrane Database Syst Rev | 2023 |
| Myocardial infarction in patients with severe beta thalassaemia: a case series. | Premawardhena A, De Silva S, Rajapaksha M, Ratnamalala V, Nallarajah J, Galappatthy G | Int J Emerg Med | 2023 |
| β-Thalassemia: all about that base, no cutting. | Ayoub PG, Kohn DB | Blood | 2023 |
| Assessment of orthodontic treatment needs in patients with β-thalassemia major and sickle cell disease. | Kalbassi S, Younesi M, Aligoudarzi SL | J Clin Pediatr Dent | 2023 |
| α- and β-Globin Gene Mutations in Individuals with Hemoglobinopathies in the Chattogram and Sylhet Regions of Bangladesh. | Kabir T, Anwar S, Mourosi JT, Akter S, Hosen MJ | Hemoglobin | 2023 |
| Longitudinal effect of disease-modifying therapy on left ventricular diastolic function in children with sickle cell anemia. | Rai P, Okhomina VI, Kang G, Martinez HR, Hankins JS, Joshi V | Am J Hematol | 2023 |
| Treatment patterns for sickle cell disease among those with cerebrovascular disease in the US. | Gelber E, Dhamoon M | Cerebrovasc Dis | 2023 |
| The Use of FDA-Approved Medications for Preventing Vaso-Occlusive Events in Sickle Cell Disease. | Cronin RM, Lin CJ, Chiang C, MacEwan S, DeBaun MR, Hyer JM | Blood Adv | 2023 |
| Induction of fetal hemoglobin: Lentiviral shRNA knockdown of HBS1L in β0-thalassemia/HbE erythroid cells. | Chumchuen S, Sripichai O, Jearawiriyapaisarn N, Fucharoen S, Peerapittayamongkol C | PLoS One | 2023 |
| Pediatric Obstructive Sleep Apnea and Sickle Cell Disease: Demographic and Polysomnographic Features. | Abijay CA, Kemper WC, Pham A, Johnson RF, Mitchell RB | Laryngoscope | 2023 |
| Real-world characteristics of patients with sickle cell disease who initiated crizanlizumab therapy. | Desai PC, Chen CC, McGuiness CB, Yasuda M, Lee S, Paulose J, He J, Yen G | Curr Med Res Opin | 2023 |
| Emergency red cell exchange for the management of acute complications in sickle cell disease: Automated versus manual. | Mihalca D, Ahmad A, Mehta D, Freeman T, Orebayo F, Bello-Sanyaolu O, Lewis N, Chatterjee B, Tsitsikas DA | Transfus Med | 2023 |
| Illness Intrusiveness in Adults with Sickle Cell Disease: The Role of Fatigue. | McGill LS, Hughes AJ, Carroll CP, Bediako SM | J Clin Psychol Med Settings | 2023 |
| Home Management and Prevention of Vaso-Occlusive Crisis of Sickle Cell Disease Knowledge among Nursing Students. | Hamid HIA, Shanmugam AJ, Alnassry SMA, Abdelgader AAM, Bashir WAH, Ali MAA, Madhappan A | J Pain Palliat Care Pharmacother | 2023 |
| Analyzing cross-talk of and genes along with evaluating therapeutic potential of in cigarette-smoke-induced lung pathophysiology in rat model. | Anwar H, Navaid S, Muzaffar H, Hussain G, Faisal MN, Ijaz MU, Riđanović S | Food Sci Nutr | 2023 |
| Allogeneic hematopoietic stem cell transplantation to cure sickle cell disease: A review. | Bhalla N, Bhargav A, Yadav SK, Singh AK | Front Med (Lausanne) | 2023 |
| Sickle Cell Trait, Clinical Manifestations and Outcomes: A Cross-Sectional Study in Colombia: Increasing Rate of Symptomatic Subjects Living in High Altitude. | Vargas-Hernández DA, Uscategui-Ruiz AC, Prada-Rueda AJ, Romero-Sánchez C | Mediterr J Hematol Infect Dis | 2023 |
| Quantitative Analysis of Liver Iron Deposition Based on Dual-Energy CT in Thalassemia Patients. | Xu F, Tang C, Huang Y, Liang L, Huang F, Yang G, Peng P | Mediterr J Hematol Infect Dis | 2023 |
| Prevalence and factors associated with hypothyroidism in children with sickle cell anemia aged 6 months - 17 years attending the Sickle Cell Clinic, Mulago Hospital, Uganda; a cross-sectional study. | Kaudha G, Piloya T, Musiime V, Kuteesa MG, Namugerwa S, Owomugisha G, Wachepa SA, Lubwama SK, Kiguli S, Tumwine JK | BMC Endocr Disord | 2023 |
| Molecular spectrum of α- and β-thalassemia among individuals of reproductive age in the Zhuhai region of southern China. | Wang X, Huang H, Zhao Y, Zhou Y, Zhang Q, Wang G | Int J Lab Hematol | 2023 |
| Predicting Pain in People With Sickle Cell Disease in the Day Hospital Using the Commercial Wearable Apple Watch: Feasibility Study. | Stojancic RS, Subramaniam A, Vuong C, Utkarsh K, Golbasi N, Fernandez O, Shah N | JMIR Form Res | 2023 |
| Reply to "Hepatocellular carcinoma in thalassemia and other hemoglobinopathies" | Origa R, Gianesin B, Longo F, Di Maggio R, Cassinerio E, Gamberini MR, Pinto VM, Casale M, La Nasa G, Caocci G, Piroddi A, Piolatto A, Di Mauro A, Romano C, Gigante A, Barella S, Maggio A, Graziadei G, Perrotta S, Forni GL | Cancer | 2023 |
| Hepatocellular carcinoma in thalassemia and other hemoglobinopathies. | Mancuso A, Butera G, Rossi M, Maringhini A | Cancer | 2023 |
| Increased risk of venous thromboembolism in splenectomized patients with sickle cell disease. | Tennenbaum J, Volle G, Pouchot J, Joseph L, Khimoud D, Ranque B, Arlet JB | Br J Haematol | 2023 |
| Premature Atherosclerosis in Children With Transfusion-Dependent Thalassemia. | Kulkarni R | Indian Pediatr | 2023 |
| infection associated with sickle cell disease: An uncommon entity. | Singh P, Patro S, Deep A, Mohapatra SK | Trop Doct | 2023 |
| Clinical and laboratory differences between pediatric hospitalized patients with sickle cell disease infected or not by SARS-CoV-2. | Elia GM, Konstantyner T, Nais RP, Santos ARAD, Angel A, Braga JAP | Rev Paul Pediatr | 2023 |
| Gender effect on production and enrichment of F cell numbers in Sickle Cell Disease patients in Tanzania. | Urio F, Nkya S, Mgaya J, Rooks H, Ponsian P, El Hoss S, Mselle T, Makani J, Menzel S | Am J Hematol | 2023 |
| Long-Term Survival with Sickle Cell Disease: A Nationwide Cohort Study of Medicare and Medicaid Beneficiaries. | Jiao B, Johnson KM, Ramsey SD, Bender MA, Devine B, Basu A | Blood Adv | 2023 |
| Hydroxyurea treatment for sickle cell anemia during pregnancy and lactation: current evidence and knowledge gaps. | Dong M, Ware RE, Dallmann A, Vinks AA | Pharmacotherapy | 2023 |
| Monitoring methaemoglobinaemia in birds using 5 μL of whole blood. | Marks CA, Trought K, Brown S, Arrow J, Hopkins B | PLoS One | 2023 |
| Shadowed by past, gene-editing summit looks to future. | Kupferschmidt K | Science | 2023 |
| Blockade of endothelin-1 receptor B regulates molecules of the major histocompatibility complex in sickle cell disease. | Inostroza-Nieves Y, Rivera A, Romero JR | Front Immunol | 2023 |
| Is this really thalassemia? | Thomas B, Visanica S, Poussing S, Gérard D, Perrin J | Am J Hematol | 2023 |
| Factors Affecting Age of Initial Specialty Clinic Evaluation Among Infants with Sickle Cell Disease in Kingston, Jamaica. | Knight-Madden J, Abar A, Smith M, Asnani M | J Pediatr | 2023 |
| "The long journey of unexplained erythrocytosis". Erythrocytosis due to high oxygen affinity hemoglobinopathy - hemoglobin variant Little Rock (HBB: c.432C>A) - A report of a Swiss Family and review of the literature | Perroud C, Porret N, Rovó A | Acta Haematol | 2023 |
| Hb Chapel Hill or Alpha2 74(EF3) Asp>Gly, a mildly unstable variant found in a Chinese family. | Tang B, Wang J, Qin D, Yao C, Chen K, Liang L, Chai H, Guo H, Du L | Hematology | 2023 |
| Whole exome sequencing and rare variant association study to identify genetic modifiers, mutations, and a novel double mutation in Thai patients with hemoglobin E/beta-thalassemia. | Hantaweepant C, Suktitipat B, Pithukpakorn M, Chinthammitr Y, Limwongse C, Tansiri N, Sawatnatee S, Takpradit C, Rotchanapanya W, Pongudom S, Charoenprasert K, Paiboonsukwong K, Thamprasert W, Nolwachai N, Rattanasawat W, Sae-Aeng B, Khorwanichakij N, Saetow P, Saengboon S, Kamjornpreecha K, Pholmoo W, Dujjawan B, Siritanaratkul N | Hematology | 2023 |
| Case report: Long-read sequencing identified a novel 14.9-kb deletion of the α-globin gene locus in a family with α-thalassemia in China. | Yuan Y, Zhou X, Deng J, Zhu Q, Peng Z, Chen L, Zou Y, Mao A, Meng W, Ma M, Wu H | Front Genet | 2023 |
| Challenges in the treatment of melanoma with BRAF and MEK inhibitors in patients with sickle cell disease: case report and review of the literature. | Diamantopoulos PT, Anastasopoulou A, Dimopoulou M, Samarkos M, Gogas H | Ther Adv Hematol | 2023 |
| The sick(le) brain and spine: neuroimaging findings in paediatric patients with sickle cell disease. | Abreu VS, Xavier S, Santos M, Lopes da Silva R, Kjöllerström P, Conceição C | Clin Radiol | 2023 |
| Reproductive Health Counseling among Youth with Sickle Cell Disease. | Stanek CJ, Reich J, Theroux CI, Creary SE, Quinn GP, Nahata L | J Pediatr Adolesc Gynecol | 2023 |
| Reticulocyte mitochondrial retention increases reactive oxygen species and oxygen consumption in mouse models of sickle cell disease and phlebotomy-induced anemia. | Gallivan A, Alejandro M, Kanu A, Zekaryas N, Horneman H, Hong LK, Vinchinsky E, Lavelle D, Diamond AM, Molokie RE, Ramasamy J, Rivers A | Exp Hematol | 2023 |
| Optimising the screening for haemoglobinopathies in pregnancy planning. | Nickel RS, Darbari DS, Martin B, Thaniel L, Stern H, Jacquot C | Hum Fertil (Camb) | 2023 |
| Aftermath of the COVID-19 Pandemic on Mental Health and Well-Being of Patients With Thalassemia Major in Pakistan: A Qualitative Study. | Hammad M, Arif R, Bano S, Ghani U, Basani HBR, Sanker V | Cureus | 2023 |
| Feasibility and Acceptability of Online Recruitment and an Online Brief Mindfulness Intervention Among Patients With Sickle Cell Disease. | Ugarte DAB, Hanley A, Dusek JA, Martin S, Cumberland W, Young S | Cureus | 2023 |
| Assessment of total and unbound cell-free heme in plasma of patients with sickle cell disease. | Vissa M, Larkin SK, Vichinsky EP, Kuypers FA, Soupene E | Exp Biol Med (Maywood) | 2023 |
| Hemoglobin and End-Organ Damage in Individuals with Sickle Cell Disease. | Ershler WB, De Castro LM, Pakbaz Z, Moynahan A, Weycker D, Delea TE, Agodoa I, Cong Z | Curr Ther Res Clin Exp | 2023 |
| Macrophage metabolic rewiring improves heme-suppressed efferocytosis and tissue damage in sickle cell disease. | Sharma R, Antypiuk A, Vance SZ, Manwani D, Pearce Q, Cox JE, An X, Yazdanbakhsh K, Vinchi F | Blood | 2023 |
| Changes in Hydroxyurea Use Among Youths Enrolled in Medicaid With Sickle Cell Anemia After 2014 Revision of Clinical Guidelines. | Reeves SL, Peng HK, Wing JJ, Cogan LW, Goel A, Anders D, Green NS, Lisabeth LD, Dombkowski KJ | JAMA Netw Open | 2023 |
| GBT021601 improves red blood cell health and the pathophysiology of sickle cell disease in a murine model. | Dufu K, Alt C, Strutt S, Partridge J, Tang T, Siu V, Liao-Zou H, Rademacher P, Williams AT, Muller CR, Geng X, Pochron MP, Dang AN, Cabrales P, Li Z, Oksenberg D, Cathers BE | Br J Haematol | 2023 |
| Effect of iron fortification on anaemia and risk of malaria among Ghanaian pre-school children with haemoglobinopathies and different ABO blood groups. | Tchum SK, Sakyi SA, Arthur F, Adu B, Abubakar LA, Oppong FB, Dzabeng F, Amoani B, Gyan T, Asante KP | BMC Nutr | 2023 |
| Gene Therapy for Rare Genetic Diseases. | Lundstrom K, Yannaki E, Chou J, A Saad F | Curr Gene Ther | 2023 |
| Acute chest syndrome in adult patients with sickle cell disease: The relationship with the time to onset after hospital admission. | Cheminet G, Brunetti A, Khimoud D, Ranque B, Michon A, Flamarion E, Pouchot J, Jannot AS, Arlet JB | Br J Haematol | 2023 |
| Gene Modification Therapies for Hereditary Diseases in the Fetus. | Mattar CNZ, Chan JK, Choolani M | Prenat Diagn | 2023 |
| Hyperammonemia and acute liver failure associated with deferasirox in two adolescents with sickle cell disease. | Towerman AS, Guilliams KP, Guerriero R, Shinawi MS, Stoll JM, Willis DN, Hulbert ML | Br J Haematol | 2023 |
| Serial prophylactic exchange blood transfusion in pregnant women with sickle cell disease (TAPS-2): statistical and qualitative analysis plan for a randomised controlled feasibility trial. | Seed PT, Brien SB, Oakley LL, Robinson V, Sharif J, Thompson H, Joseph J, Oteng-Ntim E | Trials | 2023 |
| Thalassaemia in China. | Wang WD, Hu F, Zhou DH, Gale RP, Lai YR, Yao HX, Li C, Wu BY, Chen Z, Fang JP, Chen SJ, Liang Y | Blood Rev | 2023 |
| Iron Status in Sickle Cell Anemia: Deficiency or Overload? | Patel VP, Pandya PR, Raval DM, Lukhi PD, Rathod VM, Khan S, Mallik S, Venugopal A, Jena A, Patel K, Patel D, Dobariya R | Cureus | 2023 |
| Are IL-1 family cytokines important in management of sickle cell disease in Sub-Saharan Africa patients? | Siransy LK, Dasse RS, Adou H, Kouacou P, Kouamenan S, Sekongo Y, Yeboah R, Memel C, Assi-Sahoin A, Moussa SY, Oura D, Seri J | Front Immunol | 2023 |
| High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on mRNA synthesis. | Papaioannou NY, Patsali P, Naiisseh B, Papasavva PL, Koniali L, Kurita R, Nakamura Y, Christou S, Sitarou M, Mussolino C, Cathomen T, Kleanthous M, Lederer CW | Front Genome Ed | 2023 |
| Fat emboli and critical illness-associated cerebral microbleeds (CICMs) in a patient with sickle cell disease: Do these 2 entities coexist? | Mohammed-Hadj S, Colard M, Delpierre I, Taccone F, Lolli VE | Radiol Case Rep | 2023 |
| The continuing global challenges of treating patients with beta-thalassemia. | Koren A | Br J Haematol | 2023 |
| In vivo evaluation of the effect of sickle cell hemoglobin S, C and therapeutic transfusion on erythrocyte metabolism and cardiorenal dysfunction. | D'Alessandro A, Nouraie SM, Zhang Y, Cendali F, Gamboni F, Reisz JA, Zhang X, Bartsch KW, Galbraith MD, Gordeuk VR, Gladwin MT | Am J Hematol | 2023 |
| Successful quality improvement project to increase hydroxyurea prescriptions for children with sickle cell anaemia. | Alvarez OA, Rodriguez-Cortes H, Clay ELJ, Echenique S, Kanter J, Strouse JJ, Buitrago-Mogollon T, Courtlandt C, Noonan L, Osunkwo I | BMJ Qual Saf | 2023 |
| Distribution characteristics and clinical phenotype analyses of hemoglobin variants in the Z region of Central Guangxi, Southern China. | Chen L, Tang N, Huang J, Wei X, Zhong Q, Yan T, Luo S | Hematology | 2023 |
| Acute chest syndrome, airway inflammation and lung function in sickle cell disease. | De A, Williams S, Yao Y, Jin Z, Brittenham GM, Kattan M, Lovinsky-Desir S, Lee MT | PLoS One | 2023 |
| Orbital bone infarction masquerading as preseptal cellulitis in a child with sickle beta-thalassaemia. | Alrajhi F, Jamjoom H, Alharbi S, Alrajhi A | BMJ Case Rep | 2023 |
| The Sickle-Cell Fiber Revisited. | Bishop MF, Ferrone FA | Biomolecules | 2023 |
| Gene therapy in sickle cell disease: Attitudes and informational needs of patients and caregivers. | Sharma A, Young A, Carroll Y, Darji H, Li Y, Mandrell BN, Nelson MN, Owens CL, Irvine M, Caples M, Jerkins LP, Unguru Y, Hankins JS, Johnson LM | Pediatr Blood Cancer | 2023 |
| Detrimental effects of sickle cell disease and hydroxycarbamide on ovarian reserve but uncertain impact on fertility. | Joseph L, Manceau S, Borderie D, Patrat C, Arlet JB, Meunier B, Cavazzana M, Santulli P, Barraud-Lange V | Blood Adv | 2023 |
| Keap1-Nrf2 Heterodimer: A Therapeutic Target to Ameliorate Sickle Cell Disease. | Chauhan W, Zennadi R | Antioxidants (Basel) | 2023 |
| Neuroimaging and Cognitive Function in Sickle Cell Disease: A Systematic Review. | Abdi SS, De Haan M, Kirkham FJ | Children (Basel) | 2023 |
| Production and Characterization of K562 Cellular Clones Hyper-Expressing the Gene Encoding α-Globin: Preliminary Analysis of Biomarkers Associated with Autophagy. | Zurlo M, Gasparello J, Cosenza LC, Breveglieri G, Papi C, Zuccato C, Gambari R, Finotti A | Genes (Basel) | 2023 |
| Modulation of Allosteric Control and Evolution of Hemoglobin. | Brunori M, Miele AE | Biomolecules | 2023 |
| Repeat transcranial Doppler ultrasound imaging in Kuwaiti children with sickle cell disease after a 10-year interval: A prospective, cohort study. | Asbeutah AM, Zahra AM, Al-Abboh H, AlMajran AA, Adekile A | Health Sci Rep | 2023 |
| Placenta-Derived Extracellular Vesicles in Pregnancy Complications and Prospects on a Liquid Biopsy for Hemoglobin Bart's Disease. | Chaemsaithong P, Luewan S, Taweevisit M, Chiangjong W, Pongchaikul P, Thorner PS, Tongsong T, Chutipongtanate S | Int J Mol Sci | 2023 |
| Epigenetic Regulation of β-Globin Genes and the Potential to Treat Hemoglobinopathies through Epigenome Editing. | Fontana L, Alahouzou Z, Miccio A, Antoniou P | Genes (Basel) | 2023 |
| Evaluation of the validity of the pre-marriage mean corpuscular volume value as a predictive test for b-thalassemia carrier status. | Almomani AA, Shraim AS, Atoom AM, Abdel MBA, Alhmoud JF | J Med Biochem | 2023 |
| Sickle Cell Disease Newborn Screening-An Audit of a Twin Island State Pilot Program. | Belle Jarvis S, Hadeed E, Lee K, Hardy-Dessources MD, Knight-Madden JM, Richardson C | Int J Neonatal Screen | 2023 |
| Food Consumption of People with Sickle Cell Anemia in a Middle-Income Country. | Teixeira TV, Da Silva ACF, Rodrigues CDSC, Brito FDSB, Canella DS, Citelli M | Nutrients | 2023 |
| Computational modeling and in vitro evaluation identified natural product-Z218 as a novel Janus kinase 2 (JAK2) inhibitor to combat β-thalassemia. | Shaikh A | Biotechnol Appl Biochem | 2023 |
| [Low-oxygen-affinity hemoglobinopathy Hemoglobin Sunshine Seth: a case report and literature review]. | Chang L, Wang CY, Li ZH, Zhou DB, Cao XX | Zhonghua Xue Ye Xue Za Zhi | 2023 |
| Sickle Cell Disease Knowledge and Reproductive Decisions: A Saudi Cross-Sectional Study. | Alsalman M, Alhamoud H, Alabdullah Z, Alsleem R, Almarzooq Z, Alsalem F, Alsulaiman A, Albeladi A, Alsalman Z | Patient Prefer Adherence | 2023 |
| Therapeutic perspective for children and young adults living with thalassemia and sickle cell disease. | Ferraresi M, Panzieri DL, Leoni S, Cappellini MD, Kattamis A, Motta I | Eur J Pediatr | 2023 |
| Non-pharmacological pain interventions for sickle cell crisis in pediatrics: A scoping review. | Ibitoye BM, Garrett B, Ranger M, Stinson J | J Pediatr Nurs | 2023 |
| Pragmatic anesthetic approach for extracranial to intracranial bypass surgery in a patient with moyamoya disease and sickle cell disease: a case report. | Lal S, Larney V | J Med Case Rep | 2023 |
| Evaluation of lung function in a German single center cohort of young patients with sickle cell disease using EIT and standard techniques. | Rein A, Ngo C, van den Berg M, Böll S, Lassay L, Kontny U, Wagner N, Leonhardt S, Tenbrock K, Verjans E | Front Med (Lausanne) | 2023 |
| Variability in sickle cell knowledge by sickle cell status. | Gilpin-Macfoy F, Perilla MJ, Koehly LM | J Genet Couns | 2023 |
| Efficacy of non-pharmacological interventions to reduce pain in children with sickle cell disease: A systematic review. | van Veelen S, Vuong C, Gerritsma JJ, Eckhardt CL, Verbeek SEM, Peters M, Fijnvandraat K | Pediatr Blood Cancer | 2023 |
| Gene Therapy for β-Hemoglobinopathies: From Discovery to Clinical Trials. | Segura EER, Ayoub PG, Hart KL, Kohn DB | Viruses | 2023 |
| Genetic regulation of fetal hemoglobin across global populations. | Cato LD, Li R, Lu HY, Yu F, Wissman M, Mkumbe BS, Ekwattanakit S, Deelen P, Mwita L, Sangeda RZ, Suksangpleng T, Riolueang S, Bronson PG, Paul DS, Kawabata E, Astle WJ, Aguet F, Ardlie K, Lopez de Lapuente Portilla A, Kang G, Zhang Y, Nouraie SM, Gordeuk VR, Gladwin MT, Garrett ME, Ashley-Koch A, Telen MJ, Custer B, Kelly S, Dinardo C, Sabino EC, Loureiro P, Carneiro-Proietti AB, Maximo C, , , Mendez A, Hammerer-Lercher A, Sheehan VA, Weiss MJ, Franke L, Nilsson B, Butterworth AS, Viprakasit V, Nkya S, Sankaran VG | medRxiv | 2023 |
| Viral Vectors in Gene Therapy: Where Do We Stand in 2023? | Lundstrom K | Viruses | 2023 |
| Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia. | Olivera JD, Zhang V, Nemeth E, Ganz T | Blood Adv | 2023 |
| Correction to 'Patients with sickle cell disease who develop end-stage kidney disease continue to experience poor survival - a 19-year United States renal data system study'. | Jeffrey C Winer, Marianne E Yee, Kenneth I Ataga, Jeffrey D Lebensburger, Rima S Zahr | Br J Haematol | 2023 |
| Piezo1 activation augments sickling propensity and the adhesive properties of sickle red blood cells in a calcium-dependent manner. | Nader E, Conran N, Leonardo FC, Hatem A, Boisson C, Carin R, Renoux C, Costa FF, Joly P, Brito PL, Esperti S, Bernard J, Gauthier A, Poutrel S, Bertrand Y, Garcia C, Saad STO, Egée S, Connes P | Br J Haematol | 2023 |
| Newborn Screening for Sickle Cell Disease. | Erhabor GE | West Afr J Med | 2023 |
| Mathematical Analysis for the Flow of Sickle Red Blood Cells in Microvessels for Bio Medical Application. | Chaturvedi P, Shah SR | Yale J Biol Med | 2023 |
| Hemolysis scavenger proteins and renal function marker in children with sickle cell disease at steady state: A cross-sectional study. | Fordjour FA, Kwarteng A, Paintsil V, Amanor E, Ackah EB, Amuzu EX, Sackey DS, Akoto AOY | Health Sci Rep | 2023 |
| Metabolic correlates to critical speed in murine models of sickle cell disease. | Cendali FI, Nemkov T, Lisk C, Lacroix IS, Nouraie SM, Zhang Y, Gordeuk VR, Buehler PW, Irwin D, D'Alessandro A | Front Physiol | 2023 |
| Genetic Variations of ferroportin-1(FPN1-8CG), TMPRSS6 (rs855791) and Hemojuvelin (I222N and G320V) Among a Cohort of Egyptian β-Thalassemia Major Patients. | El-Gharbawi N, Shaheen I, Hamdy M, Elgawhary S, Samir M, Hanna BM, Ali EY, Youssef EA | Indian J Hematol Blood Transfus | 2023 |
| Economic Evaluation of Nucleic Acid Testing for Screening of Blood Donations for Thalassemia Patients (ECONAT) in Western India. | Anne PB, Gupta A, Misra S, Sharma SK, Garg MK, Bajpayee A, Bundas S, Bohra M, Asirvatham V | Indian J Hematol Blood Transfus | 2023 |
| Structural and oxidative investigation of a recombinant high-yielding fetal hemoglobin mutant. | Kettisen K, Nyblom M, Smeds E, Fago A, Bülow L | Front Mol Biosci | 2023 |
| Adherence to hydroxyurea and clinical outcomes among children with sickle cell anemia. | Reeves SL, Dombkowski KJ, Peng HK, Phan H, Kolenic G, Creary SE, Madden B, Lisabeth LD | Pediatr Blood Cancer | 2023 |
| Feasibility study of busulfan, fludarabine, and thiotepa conditioning regimen for allogeneic hematopoietic stemcell transplantationfor children and young adults with nonmalignant disorders. | Fraser A, Castillo P, Cascio E, Moore-Higgs G, Farhadfar N, Fort J, Slayton W, Lamba J, Horn B | Pediatr Blood Cancer | 2023 |
| Avascular necrosis in both hips in a patient with transfusion dependent β-thalassaemia. | Pepe J, Cipriani C, Colangelo L, Minisola S | Lancet | 2023 |
| HBB Gene Mutations and Their Pathological Impacts on HbE/β-Thalassaemia in Kuala Terengganu, Malaysia. | Saad HKM, Taib WRW, Ab Ghani AS, Ismail I, Al-Rawashde FA, Almajali B, Alhawamdeh M, Abd Rahman AA, Al-Wajeeh AS, Al-Jamal HAN | Diagnostics (Basel) | 2023 |
| Transforming Growth Factor Beta 1 (TGF-β1) as a Potential Biomarker in Children with Sickle Cell Disease. | Ilonze C, Anderson M, Stubblefield A, McNall-Knapp R, Braly E, Journeycake J, Sinha AA | J Pediatr Hematol Oncol | 2023 |
| Discovery of potent DNMT1 inhibitors against sickle cell disease using structural-based virtual screening, MM-GBSA and molecular dynamics simulation-based approaches. | Ala C, Joshi RP, Gupta P, Ramalingam S, Sankaranarayanan M | J Biomol Struct Dyn | 2023 |
| Plasmodium falciparum-Induced Autoimmune Hemolytic Anemia in a Pregnant Patient with Sickle Cell Disease. | Rupani KV, Waksal J, Cytryn L, Naymagon L | Am J Case Rep | 2023 |
| Alloimmunisation against red blood cells in sickle cell disease: transfusion challenges in high-income and low-income countries. | Pirenne F, Floch A, Diop S | Lancet Haematol | 2023 |
| Parental perspective on the risk of infertility and fertility preservation options for children and adolescents with sickle cell disease considering hematopoietic stem cell transplantation. | Sinha CB, Meacham LR, Bakshi N, Ross D, Krishnamurti L | Pediatr Blood Cancer | 2023 |
| Evaluation of parafoveal and peripapillary vascular densities using optical coherence tomography angiography in children with thalassemia major. | Dursun ME, Hazar L, Karahan M, Erdem S, Ava S, Üzel VH, Dursun B, Keklikçi U | Ther Adv Ophthalmol | 2023 |
| [Lung manifestations of sickle-cell disease]. | Hamzaoui A, Louhaichi S, Hamdi B | Rev Mal Respir | 2023 |
| Role of Macrophages in Sickle Cell Disease Erythrophagocytosis and Erythropoiesis. | Sesti-Costa R, Costa FF, Conran N | Int J Mol Sci | 2023 |
| Desire for biological parenthood and patient counseling on the risk of infertility among adolescents and adults with hemoglobinopathies. | Radauer-Plank AC, Diesch-Furlanetto T, Schneider M, Sommerhäuser G, Friedrich LA, Salow V, Dülberg J, Diepold M, Rovó A, Njue LM, Drexler B, Infanti L, Kroiss S, Merki R, Scheinemann K, Eisenreich B, Hegemann I, Mandic L, Kager L, Borgmann-Staudt A, Schilling R, Roll S, Balcerek M | Pediatr Blood Cancer | 2023 |
| Cerebral revascularization surgery reduces cerebrovascular events in children with sickle cell disease and moyamoya syndrome: Results of the stroke in sickle cell revascularization surgery retrospective study. | Aldana PR, Hanel RA, Piatt J, Han SH, Bansal MM, Schultz C, Gauger C, Pederson JM, Iii JCW, Hulbert ML, Jordan LC, Qureshi A, Garrity K, Robert AP, Hatem A, Stein J, Beydler E, Adelson PD, Greene S, Grabb P, Johnston J, Lang SS, Leonard J, Magge SN, Scott A, Shah S, Smith ER, Smith J, Strahle J, Vadivelu S, Webb J, Wrubel D | Pediatr Blood Cancer | 2023 |
| Long-Term Health-Related Quality of Life and Clinical Outcomes in Patients with β-Thalassemia after Splenectomy. | Caocci G, Mulas O, Barella S, Orecchia V, Mola B, Costa A, Efficace F, La Nasa G | J Clin Med | 2023 |
| Ischemic stroke in a pediatric patient with very rare coexistence of sickle-cell/β-thalassemia and neurofibromatosis type 1. | Roka K, Solomou E, Glentis S, Gavra M, Kokkinou E, Rigatou E, Pons R, Kattamis A | Pediatr Blood Cancer | 2023 |
| Commentary on the ASH 2020 Guidelines on Cognitive Screening and Intervention in Sickle Cell Disease. | Hoyt CR, Heitzer AM, Hardy SJ | Blood Adv | 2023 |
| Effects of GBT1118, a voxelotor analog, on intestinal pathophysiology in sickle cell disease. | Haroun E, Dutta D, Lim SH | Br J Haematol | 2023 |
| Preliminary Construct Validity of Patient-Reported Outcomes to Assess Chronic Pain in Adults with Sickle Cell Disease. | Mucalo L, Field JJ, Highland J, Khan H, Hankins JS, Singh A, Brandow AM | Blood Adv | 2023 |
| FXII and sickle cell: the clot thickens. | Shet AS | Blood | 2023 |
| Infertility and treatment-seeking practices among females and males with sickle cell disease in the Sickle Cell Disease Implementation Consortium registry. | Stevenson E, Tanabe P, Knisely M, Masese R, Bulgin D, Preiss L, Hankins JS, King AA, Gordeuk V, Shah N | Pediatr Blood Cancer | 2023 |
| Treating Thalassemia Patients with Luspatercept: An Expert Opinion Based on Current Evidence. | Longo F, Motta I, Pinto V, Piolatto A, Ricchi P, Tartaglione I, Origa R | J Clin Med | 2023 |
| Management of luspatercept therapy in patients with transfusion-dependent β-thalassaemia. | Sheth S, Taher AT, Coates TD, Kattamis A, Cappellini MD | Br J Haematol | 2023 |
| Dry eye in thalassemia. | Ravishankar R, Parab A, Christy JS | Indian J Ophthalmol | 2023 |
| Treating Chronic Pain in Sickle Cell Disease - The Need for a Biopsychosocial Model. | Childerhose JE, Cronin RM, Klatt MD, Schamess A | N Engl J Med | 2023 |
| Determining the current prevalence of β-thalassemia variants in Jordan. | Hasan D, Al Tibi A, Burghel G, Abdelnour A | Arch Med Sci | 2023 |
| Growing beyond sickle cell disease: A metasynthesis of children, adolescents, and young adult experiences living with sickle cell disease. | Coco M, Henderson WA, Park CL, Starkweather AR | Res Nurs Health | 2023 |
| Neurocognitive and emotional factors predict pain-related healthcare utilization in children with sickle cell disease. | Hardy SJ, Williams Z, Berger C, Griffin D, Weisman H, Liang H, Darbari DS | Pediatr Blood Cancer | 2023 |
| An analysis of the distribution and spectrum of alpha thalassemia mutations in Rasht City, North of Iran. | Asghari Ahmadabad M, Pourreza N, Ramezanpour S, Baghersalimi A, Enshaei M, Askari M, Alizadeh A, Izadi E, Darbandi B | Front Pediatr | 2023 |
| Burden experienced by informal caregivers of children with sickle cell disease (SCD): a qualitative exploratory study at Tamale Teaching Hospital, Ghana. | Mumuni ND, Osman W, Alhassan BA, Alhassan A | BMJ Open | 2023 |
| Quantification of cardiac iron in patients with thalassemia with 3-T MRI calibrated by 1.5-T MRI. | Xu F, Luo C, Li M, Guan K, Peng F, Yang G, Peng P | Acta Radiol | 2023 |
| Tailoring a Digital Mental Health Program for Patients With Sickle Cell Disease: Qualitative Study. | Nikolajski C, O'Brien J, Nardo E, Szigethy E, Jonassaint C | JMIR Ment Health | 2023 |
| Cognitive-motor dual-task interference in adults with sickle cell disease. | Subramaniam AP, Oyedeji CI, Parikh JS, Feld JA, Strouse JJ | Gait Posture | 2023 |
| [Patient partnership: sharing experience in sickle cell vaso-occlusive crisis]. | Loiret L, Marquet L, Lioger B, Stankovic Stojanovic K | Rev Infirm | 2023 |
| Correction: Enuresis and overactive bladder in sickle cell patients: a narrative review of the literature. | Gaye O, Seck M, Thiam NM, Ndong A, Fall PA | World J Urol | 2023 |
| The Prevalence of Cardiovascular Manifestations in Pediatric Sickle Cell Anemia Patients in a Large Tertiary Care Hospital in the Western Region of Saudi Arabia. | Waggass R, Alhindi AK, Bagabas IS, Alsaegh MH, Alsharef NK, Morya RE, Khan MA, Jastaniah W | Cureus | 2023 |
| Genotypic spectrum of α-thalassemia and β-thalassemia in newborns of the Li minority in Hainan province, China. | Zhong K, Shi H, Wu W, Xu H, Wang H, Zhao Z | Front Pediatr | 2023 |
| Managing Sickle Cell Disease in Patients for Whom Blood Transfusion Is Not an Option. | Tabiti BF, Ozawa S, Mian A, Suri M, Yates HL, Hsu LL | Hematol Oncol Stem Cell Ther | 2023 |
| The impact of COVID-19 in children with Sickle Cell Disease: Results of a multicentric registry. | Oliveira CM, Soares VJ, Pellegrini Braga JA, Alcantara Bonilha T, Magalhães I, Loggetto SR, Rechenmacher C, Daudt LE, Michalowski MB | PLoS One | 2023 |
| Proinflammatory state promotes red blood cell alloimmunization in pediatric patients with sickle cell disease. | Zheng Y, Gossett JM, Chen PL, Barton M, Ryan M, Yu J, Kang G, Hankins JS, Chou ST | Blood Adv | 2023 |
| Walter O, Cougoul P, Maquet J, et al. Risk of vaso-occlusive episode after exposure to corticosteroids in patients with sickle cell disease. Blood. 2022;139(26):3771-3777. | Walter O, Cougoul P, Maquet J, et al. | Blood | 2023 |
| Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD). | Gomez-Arteaga A, Orfali N, Pasciolla M, Baptiste A, Guindine I, Hsu J, Lin J, Mayer SA, Phillips AA, Shore TB, Simonson PD, DiCarlo E, Yoon S, Muthukumar T, van Besien K | Bone Marrow Transplant | 2023 |
| Longitudinal Predictors of Pain in Pediatric Sickle Cell Disease. | Karlson CW, Barajas KG, Seals SR, Britt AB, Schlenz AM, Jackson EA, Davis DB, Morris MC, Valrie CR | J Pediatr Psychol | 2023 |
| Secondary Malignancies After Allogeneic Hematopoietic Stem Cell Transplantation for Sickle Cell Disease Inform Gene Therapy Approaches. | Meisel R | J Clin Oncol | 2023 |
| Femoral Head Core Decompression and Bone Marrow Concentrate Injection in Pediatric Sickle-cell Related Avascular Necrosis. | Baghdadi S, Chern I, Hanstein R, Mehraban Alvandi L, Fornari E | J Pediatr Orthop | 2023 |
| Molecular evolution of the hemoglobin gene family across vertebrates. | Mao Y, Peng T, Shao F, Zhao Q, Peng Z | Genetica | 2023 |
| Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice. | Everette KA, Newby GA, Levine RM, Mayberry K, Jang Y, Mayuranathan T, Nimmagadda N, Dempsey E, Li Y, Bhoopalan SV, Liu X, Davis JR, Nelson AT, Chen PJ, Sousa AA, Cheng Y, Tisdale JF, Weiss MJ, Yen JS, Liu DR | Nat Biomed Eng | 2023 |
| Making the 'genetic counsellor' in the UK, 1980-1995. | Bangham J | Med Humanit | 2023 |
| Outcome of premarital genetic counseling for couples at risk of hemoglobinopathies in Kingdom of Bahrain. | Bahram S, Haji A, Abdulwahab H, Mohsen H, Alnashaba T, Al-Aradi Z, Mandeel M | J Med Screen | 2023 |
| Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients, as a function of therapeutic transfusion and hydroxyurea treatment. | D'Alessandro A, Nouraie SM, Zhang Y, Cendali F, Gamboni F, Reisz JA, Zhang X, Bartsch KW, Galbraith MD, Espinosa JM, Gordeuk VR, Gladwin MT | bioRxiv | 2023 |
| Proliferative Sickle Cell Retinopathy in the Retinal Periphery Detected by Ultra-Widefield Imaging: A Case Report. | Giocanti-Aurégan A, Fajnkuchen F | Case Rep Ophthalmol | 2023 |
| The Evaluation of Renal Iron Deposition With a 3 Tesla MRI Device in Beta-Thalassemia Major Patients. | Guzelbey T, Demirbaş ZE, Gurses B | Cureus | 2023 |
| Cemented Versus Uncemented Total Hip Arthroplasty in Sickle Cell Disease Patients: A Retrospective Study. | Almarzooq O, Alhassan M, Alansari L, Alanazi T, Madan FH | Cureus | 2023 |
| Silent infarction in sickle cell disease is associated with brain volume loss in excess of infarct volume. | Jones RS, Donahue MJ, Davis LT, Pruthi S, Waddle SL, Custer C, Patel NJ, DeBaun MR, Kassim AA, Rodeghier M, Jordan LC | Front Neurol | 2023 |
| Effects of l-arginine supplementation in patients with sickle cell disease: A systematic review and meta-analysis of clinical trials. | Sadeghi A, Taherifard E, Dehdari Ebrahimi N, Rafiei E, Hadianfard F, Taherifard E | Health Sci Rep | 2023 |
